Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Richard Steven Blumberg, M.D.

Co-Author

This page shows the publications co-authored by Richard Blumberg and Yu-Hwa Huang.
Connection Strength

2.520
  1. Corrigendum: CEACAM1 regulates TIM-3-mediated tolerance and exhaustion. Nature. 2016 08 18; 536(7616):359.
    View in: PubMed
    Score: 0.655
  2. CEACAM1 regulates TIM-3-mediated tolerance and exhaustion. Nature. 2015 01 15; 517(7534):386-90.
    View in: PubMed
    Score: 0.595
  3. SLAM-ing the brakes on iNKT cell selection. Nat Immunol. 2019 04; 20(4):378-379.
    View in: PubMed
    Score: 0.202
  4. CEACAM1 structure and function in immunity and its therapeutic implications. Semin Immunol. 2019 04; 42:101296.
    View in: PubMed
    Score: 0.202
  5. High resolution X-ray and NMR structural study of human T-cell immunoglobulin and mucin domain containing protein-3. Sci Rep. 2018 11 30; 8(1):17512.
    View in: PubMed
    Score: 0.198
  6. New Insights Into the Regulation of Natural-Killer Group 2 Member D (NKG2D) and NKG2D-Ligands: Endoplasmic Reticulum Stress and CEA-Related Cell Adhesion Molecule 1. Front Immunol. 2018; 9:1324.
    View in: PubMed
    Score: 0.191
  7. CEACAM1 on activated NK cells inhibits NKG2D-mediated cytolytic function and signaling. Eur J Immunol. 2013 Sep; 43(9):2473-83.
    View in: PubMed
    Score: 0.135
  8. The short isoform of the CEACAM1 receptor in intestinal T cells regulates mucosal immunity and homeostasis via Tfh cell induction. Immunity. 2012 Nov 16; 37(5):930-46.
    View in: PubMed
    Score: 0.130
  9. CEACAM1 dampens antitumor immunity by down-regulating NKG2D ligand expression on tumor cells. J Exp Med. 2011 Dec 19; 208(13):2633-40.
    View in: PubMed
    Score: 0.122
  10. Blockade of Tim-3 binding to phosphatidylserine and CEACAM1 is a shared feature of anti-Tim-3 antibodies that have functional efficacy. Oncoimmunology. 2018; 7(2):e1385690.
    View in: PubMed
    Score: 0.046
  11. CEACAM1 as a multi-purpose target for cancer immunotherapy. Oncoimmunology. 2017; 6(7):e1328336.
    View in: PubMed
    Score: 0.044
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.